Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
Rangering i aksjer #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Aksjekurs
$99.32
Markedsverdi
$48.20B
Endring (1 dag)
0.98%
Endring (1 år)
-32.14%
Land
AU
Handel CSL Limited (CSL)

Kategori

EPS for CSL Limited (CSL)
EPS per December 2025 TTM: $2.98
Ifølge de siste økonomiske rapportene og aksjekursen til CSL Limited er selskapets nåværende EPS (TTM) $2.98. Ved slutten av 2024 hadde selskapet en EPS på $5.47, en økning sammenlignet med EPS-en i 2023 som var $4.55.
EPS-historikk for CSL Limited fra 2000 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $2.98 -51.94%
2025 $6.20 13.35%
2024 $5.47 20.22%
2023 $4.55 -31.37%
2022 $6.63 26.05%
2021 $5.26 13.61%
2020 $4.63 9.20%
2019 $4.24 50.89%
2018 $2.81 -4.42%
2017 $2.94 9.29%
2016 $2.69 -7.88%
2015 $2.92 8.15%
2014 $2.70 21.09%
2013 $2.23 12.45%
2012 $1.98 -0.58%
2011 $1.99 49.05%
2010 $1.34 6.70%
2009 $1.25 7.16%
2008 $1.17 64.09%
2007 $0.71 500.34%
2006 $0.12 -78.01%
2005 $0.54 168.22%
2004 $0.20 202.40%
2003 $0.07 -21.18%
2002 $0.08 -5.06%
2001 $0.09 83.13%
2000 $0.05 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$3.62 21.55%
DK
$15.47 419.13%
US
$43.12 1,346.98%
US
$9.62 222.85%
BE
$38.32 1,185.91%
NL